Hot flashes, sleep disturbances, and mood changes are well-known symptoms of perimenopause and menopause. However, researchers are increasingly recognizing another area significantly affected by hormonal changes: the eyes.
While many women expect changes in their skin, metabolism, or bone health during menopause, few realize that fluctuating hormone levels can affect tear production, visual comfort, eye inflammation, and potentially even long-term eye disease risk.
Recent studies are helping physicians better understand the connection between hormonal changes and eye health, highlighting why women should pay close attention to their vision during the menopausal transition.
Dry Eye Disease Is More Than a Comfort Issue
The most established connection between menopause and eye health is dry eye disease.
Research continues to show that women experience dry eye at significantly higher rates than men, with symptoms often increasing during perimenopause and after menopause. Recent studies presented through The Menopause Society found that postmenopausal women experience dry eye disease more frequently than women in perimenopause, suggesting that symptoms may worsen as hormonal changes progress.
Dry eye disease develops when the eyes cannot maintain a stable, healthy tear film. Many people assume tears are simply water, but healthy tears actually consist of three layers:
- A mucus layer that helps tears adhere to the eye
- A watery layer that provides moisture
- An oil layer that prevents rapid evaporation
Disruption of any layer can lead to symptoms.
Women experiencing menopause-related dry eye often report:
- Burning
- Stinging
- Redness
- Excessive tearing
- Blurred or fluctuating vision
- Sensitivity to light
- A gritty or sandy sensation
Importantly, dry eye is not always just an inconvenience. Chronic ocular surface inflammation can affect quality of life, reading, computer use, driving, and overall visual comfort.
Researchers Are Looking Beyond Tear Production
One of the most interesting developments in recent eye research is the growing focus on the meibomian glands.
These tiny glands located along the eyelid margins produce the oils that help prevent tears from evaporating too quickly.
Emerging research suggests hormonal changes associated with menopause may affect the function of these glands, contributing to what specialists call evaporative dry eye disease. Researchers now believe meibomian gland dysfunction may play a larger role in menopausal eye symptoms than previously recognized.
This finding is important because some women who complain of dry eye symptoms may actually have normal tear volume. The problem may instead involve tear quality and tear stability.
In practical terms, the issue may not be that the eyes are producing too few tears—but that tears are evaporating too quickly.
Inflammation May Be a Missing Piece of the Puzzle
Historically, menopause-related eye symptoms were primarily attributed to declining estrogen levels.
Newer research suggests the story may be more complex.
Scientists are increasingly studying the role of inflammation within the ocular surface. Recent reviews propose that hormonal fluctuations may alter immune activity within the eye, creating a cycle of inflammation that contributes to dry eye disease and ocular surface irritation.
This evolving understanding may help explain why some women continue experiencing symptoms even when standard artificial tears provide only limited relief.
Researchers continue to investigate how hormone changes, inflammation, and gland function interact to affect long-term eye health.
What About Hormone Replacement Therapy?
Another area receiving significant attention is hormone replacement therapy.
The relationship between hormone therapy and eye health remains complex.
Some studies suggest certain hormone therapies may improve aspects of ocular surface health, while others have reported increased rates of dry eye symptoms among women using specific hormone regimens. More recent investigations are exploring whether targeted hormone-based approaches could help relieve severe dry eye symptoms in some patients.
The takeaway for patients is not that hormone therapy helps or harms every woman equally. Rather, researchers now recognize that the relationship between hormones and eye health is highly individualized and continues to be an active area of investigation.
Potential Links to Glaucoma Risk
One of the more intriguing developments in women’s eye health research involves glaucoma.
Glaucoma is a progressive eye disease that damages the optic nerve and remains one of the leading causes of irreversible vision loss worldwide.
Recent research has explored whether menopause-related hormonal changes may influence glaucoma risk. Some studies suggest menopausal hormone therapy may be associated with a lower risk of glaucoma in certain women, particularly those who experience menopause earlier in life. Researchers are continuing to investigate the potential protective effects hormones may have on the optic nerve and eye circulation.
While more research is needed before treatment recommendations change, these findings underscore how closely eye health may be connected to hormonal health.
Why Women Should Not Ignore Eye Symptoms During Midlife
One challenge with menopause-related eye changes is that symptoms often develop gradually.
Many women assume that burning, irritation, blurred vision, or increased sensitivity to light are simply part of aging. In reality, these symptoms may indicate underlying dry eye disease, meibomian gland dysfunction, or other ocular surface conditions that can often be treated successfully when identified early.
Perimenopause and menopause represent a time of significant change throughout the body, and the eyes are no exception.
As research continues to evolve, one message remains clear: eye health should be considered an important part of overall women’s health. Routine comprehensive eye examinations can help identify changes early, evaluate bothersome symptoms, and ensure that vision remains protected throughout every stage of life. To schedule an appointment with us, call (770) 475-0123.